Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the safety of the study drug, Patanase (Olopatadine
Hydrochloride Nasal Spray 0.6%) compared to placebo (inactive substance) in children ages 2
to less than 6 who have a history of nasal allergies, and to assess the pharmcokinetics
(study of the action of a drug in the body) in these children